Genomic technologies are redefining the understanding of genotype-phenotype relationships and over the past decade, many bioinformatics algorithms have been developed to predict functional consequences of single nucleotide variants. This article presents the data from a comprehensive computational workflow adopted to assess the biomedical impact of the DNA variants resulting from the experimental study "Molecular analysis of sarcomeric and non-sarcomeric genes in patients with hypertrophic cardiomyopathy" (Bottillo et al., 2016) [1]. Several different independently methods were employed to predict the functional consequences of alleles that result in amino acid substitutions, to study the effect of some DNA variants over the splicing process and
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Value of the data
These data delineate a prompt informatic pipeline for the prioritization of the most likely pathogenetic DNA variants in a clinical context.
These data are supportive for the researchers to evaluate the prevalence of sarcomeric and nonsarcomeric gene variants in hypertrophic cardiomyopathy.
The described computational strategy is helpful to researchers for the rapid interpretation of
Variants of Unknown Significance (VUS) implicated in rare, common and complex diseases.
Data
Here we report the in silico predictions data of the non-synonymous changes found in 41 HCM patients and in 3 HCM-related cases [1] (Table 1) .
Experimental design, materials and methods

Analysis of the nucleotides' evolutionary conservation
Nucleotide-specific estimates of evolutionary constraint were explored by (i) GERP þ þ (Genomic Evolutionary Rate Profiling); (ii) PhyloP placental; (iii) PhyloP veterbrate and (iv) SiPhy.
2..2. Analysis of the splicing variants
The analysis of intronic variants leading to splicing defects was tested by Human Splicing Finder (HSF) 3.0. Regarding the molecular modeling, protein structure were experimentally determined by X-ray crystallography, or were inferred by homology modeling means (i.e., availability of a structural template with percentage of identity 4 20%). Protein models were built using the homology modeling approach implemented in modeler-9 package [2] . PSI-BLAST was used to find suitable structural templates for each sequence to model [3] . The sequences of each protein target to model and its structural template were then aligned by using the program CLUSTALW [4] and manually manipulated to optimize the matching of several characteristics, including the observed and predicted secondary structural elements, the hydrophobic regions in the three-dimensional structures, the structurally and functionally conserved residues, and indel regions in the structures. Then, ten different models were built for each target protein and evaluated using several criteria. The model displaying the lowest objective function [5] , which measures the extent of violation of constraints from the structural templates, was taken as the representative model. Superimposition and root-mean-square deviation (RMSD) calculation of Cα traces of the 10 models were performed to detect the most variable and therefore less reliable modeled regions. These invariably corresponded to loop elements. Procheck [6] was used to monitor the stereochemical quality of the representative models, whereas ProsaII [7] was used to measure the overall protein quality in packing and solvent exposure. Mutations on protein structures was carried out using the "Mutate model" script implemented in modeler-9 package [2] . The script takes as input a given three-dimensional structure of a protein (experimentally determined or predicted), and mutates a single residue. The residue sidechain's position is then optimized by energy minimization and refined by molecular dynamics simulations. Prediction of protein stability upon mutation was carried out using the DUET server [8] . Sequence identity between the modeled domain and its closest template ranged from 23% (Laminin G-like domain of LAMA4), to nearly 95% (N-terminal globular head domain of VCL). However, in spite of the low value of sequence identity measured in some cases, all of the models resulted in a good overall quality (Prosa Z-score o À 2.00), except for CALR3 and SCN5. Given the short length of the predicted PB035848 domain of CALR3 (residues 294-347) and its sequence identity with its template (61%), the measured Prosa Zscore ( À1.93) nonetheless indicated a model of quality comparable to a Nuclear Magnetic Resonance (NMR) structure [7] ( Figs. 1 and 2 ).
